T1	Participants 0 53	Chemotherapy of advanced gastric carcinoma (stage IV)
T2	Participants 105 166	Forty-six patients with advanced gastric carcinoma (Stage IV)
T3	Participants 312 389	Treatment groups were well balanced with respect to known prognostic factors.
T4	Participants 524 559	median survival of the entire group
T5	Participants 1296 1339	Thirteen patients with unmeasurable disease
